A Randomized Controlled Trial Using Turmeric for Patients With Basal Joint Arthritis
Status: Recruiting
Location: See location...
Intervention Type: Dietary supplement, Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
The aim of this study is to assess whether the use of a commercially available nutraceutical, turmeric, is an effective option to manage pain and stiffness in patients with basal joint arthritis. To conduct a pilot Randomized Controlled Trial evaluating the impact of turmeric on basal joint arthritis.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 40
Healthy Volunteers: f
View:
• 40 years of age or older
• English fluency and literacy
• Seeking care for basal joint pain
• Tender over basal joint
• Positive distraction rotation test (rotation of the thumb metacarpal base while applying axial traction)
• Radiographic evidence of Eaton stage 1 and 2 only
Locations
United States
Massachusetts
Massachusetts General Hospital
RECRUITING
Boston
Contact Information
Primary
Neal Chen, M.D.
nchen1@mgh.harvard.edu
617-726-4700
Backup
Karan Amin, BA
kamin2@mgh.harvard.edu
Time Frame
Start Date: 2017-08-09
Estimated Completion Date: 2028-01
Participants
Target number of participants: 60
Treatments
Experimental: Turmeric
Subjects in this group will receive turmeric (100 mg pastille) 3 times per day for 6 weeks.
Placebo_comparator: Control
Subjects in this group will receive a placebo pill 3 times per day for 6 weeks.
Related Therapeutic Areas
Sponsors
Leads: Massachusetts General Hospital